Gait Disorders, Neurologic
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Innovation PharmaceuticalsExerG
Neuron BiopharmaLexo
Heidelberg PharmaFemoral Derotation Osteotomy
Clinical Trials (3)
Total enrollment: 50 patients across 3 trials
ExerG: Video Game-based Physical Cognitive Training for Patients: a Usability Study
Start: May 2023Est. completion: Oct 202320 patients
N/AUnknown
Effectiveness of Multiple Robotic Gait-Devices for Improving Walking Ability in Subacute Stroke Patients
Start: Mar 2023Est. completion: Aug 20240
N/AWithdrawn
Controlling Femoral Derotation Osteotomy In Cerebral Palsy With Electromagnetic Tracking
Start: Dec 2017Est. completion: Dec 202130 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.